Terns Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BURROUGHS AMY L. director, officer: Chief Execut..
 Common Stock 15,450 $7.15 $110,468
Purchase
LU HONGBO director
 Common Stock 285,714 $10.5 $2,999,997
Purchase
LU HONGBO director
 Common Stock 190,476 $10.5 $1,999,998
Option
VIGNOLA MARK J. officer: Chief Financial Officer
 Common Stock 10,000 $5.36 $53,600
Sale
VIGNOLA MARK J. officer: Chief Financial Officer
 Common Stock 10,000 $11 $110,000
Option
VIGNOLA MARK J. officer: Chief Financial Officer
 Stock Option (Right to Buy) 10,000 $5.36 $53,600
Option
QUIGLEY JILL M. director
 Common Stock 17,235 $1.82 $31,368
Sale
QUIGLEY JILL M. director
 Common Stock 17,235 $10 $172,350
Option
QUIGLEY JILL M. director
 Stock Option (Right to Buy) 17,235 $1.82 $31,368
Sale
QUIGLEY JILL M. director
 Common Stock 8,857 $7.5 $66,436
Sale
QUIGLEY JILL M. director
 Common Stock 6,143 $7.68 $47,148
Sale
GORDON CARL L director, 10 percent owner:
Common Stock 4,009 $10 $40,090
Sale
GORDON CARL L director, 10 percent owner:
Common Stock 556 $10 $5,560
Sale
GORDON CARL L director, 10 percent owner:
Common Stock 623 $10 $6,230
Sale
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 4,009 $10 $40,090
Sale
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 556 $10 $5,560
Sale
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 623 $10 $6,230
Option
QUIGLEY JILL M. director
 Common Stock 400 $1.82 $728
Sale
QUIGLEY JILL M. director
 Common Stock 400 $10 $4,000
Option
QUIGLEY JILL M. director
 Stock Option (Right to Buy) 400 $1.82 $728
Sale
GORDON CARL L director, 10 percent owner:
Common Stock 39,433 $10 $394,330
Sale
GORDON CARL L director, 10 percent owner:
Common Stock 5,401 $10 $54,010
Sale
GORDON CARL L director, 10 percent owner:
Common Stock 6,142 $10 $61,420
Sale
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 39,433 $10 $394,330
Sale
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 5,401 $10 $54,010
Sale
ORBIMED ADVISORS LLC director, 10 percent owner:
Common Stock 6,142 $10 $61,420
Option
QUIGLEY JILL M. director
 Common Stock 14,365 $1.82 $26,144
Sale
QUIGLEY JILL M. director
 Common Stock 14,365 $10 $143,664
Option
QUIGLEY JILL M. director
 Stock Option (Right to Buy) 14,365 $1.82 $26,144
Purchase
YOON SEOKHO BRYAN officer: COO and General Counsel
 Common Stock 4,791 $4.44 $21,272
Purchase
VIGNOLA MARK J. officer: Chief Financial Officer
 Common Stock 4,791 $4.44 $21,272
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 103,870 $6.2 $643,994
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 30,047 $6.2 $186,291
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 4,149 $6.2 $25,724
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 76,346 $6.65 $507,701
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 22,084 $6.65 $146,859
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 3,050 $6.65 $20,283
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 136,255 $6.99 $952,422
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 39,411 $6.99 $275,483
Sale
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 5,451 $6.99 $38,102
Purchase
YOON SEOKHO BRYAN officer: COO and General Counsel
 Common Stock 743 $3.78 $2,809
Purchase
VIGNOLA MARK J. officer: Chief Financial Officer
 Common Stock 743 $3.78 $2,809
Purchase
VIGNOLA MARK J. officer: Chief Financial Officer
 Common Stock 9,997 $1.41 $14,096
Purchase
YOON SEOKHO BRYAN officer: COO and General Counsel
 Common Stock 9,997 $1.41 $14,096
Purchase
SUNDARAM SENTHIL VEL director, officer: Chief Execut..
 Common Stock 2,111 $1.41 $2,977
Purchase
ORBIMED ADVISORS LLC director, 10 percent owner
 Common Stock 137,931 $7.25 $1,000,000
Purchase
GORDON CARL L director, 10 percent owner
 Common Stock 137,931 $7.25 $1,000,000
Purchase
VIVO OPPORTUNITY, LLC 10 percent owner
 Common Stock 758,620 $7.25 $5,499,995
Purchase
LU HONGBO director
 Common Stock 758,620 $7.25 $5,499,995
Sale
LAV BIOSCIENCES FUND V, L.P. 10 percent owner
 Common Stock 166,666 $5.5 $916,663

Showing 1 to 50 of 81 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: